Evidence-based remote monitoring and behavioural treatment for children, young people and adults. Used by NHS specialist services and private providers across the UK.
CEW specialist services, community paediatrics, Tier 2 lifestyle programmes, school health.
View paediatric solutions โNHS Tier 3, bariatric pre-op, GP-referred programmes, GLP-1 behavioural support.
View adult solutions โObesity is a chronic condition โ yet most services still deliver short, clinic-bound 12-week programmes. They are resource-heavy, hard to sustain and end up driving repeat demand. In England, 66% of adults and 26% of children aged 2โ15 are overweight or living with obesity.
Evira takes a different route: continuous digital support running alongside clinical care, so teams can deliver long-term follow-up without scaling staff in proportion. Sustained behavioural change instead of episodic care.
NHS Digital 2024 ยท Health Survey for England, Jan 2026
Evira bridges the gap between clinic visits with daily remote monitoring, family messaging and proactive intervention โ so teams can deliver high-quality care even when distances are great.
A connected scale at home โ no numbers shown. Daily measurements flow straight to the clinical dashboard.
Families reach their care team whenever they need to. AI-powered translation supports multilingual populations.
The full treatment history is available to the multidisciplinary team. Search, filter and sort. 2โ4 minutes per patient per week.
Individualised height-growth predictions yield real-time, accurate BMI SDS values for children and young people.
Simple visual indicators for varying health literacy plus AI translation in messaging โ accessible to diverse populations.
Several household members can use the same device with separate secure accounts โ supporting family-wide collaboration.
Around 10% of children in UK CEW services using Evira are now also receiving GLP-1 medication. Evira provides the behavioural monitoring, dosing communication and lifestyle support that make pharmacotherapy more effective.
Learn about Evira & GLP-1 โDTAC, DSPT, Cyber Essentials, DCB0129, CE marked, ICO registered. We provide complete evidence packs to accelerate your procurement.
Digital Technology Assessment Criteria.
Clinical risk management standards.
Data Security & Protection Toolkit.
Medical device, class I.
Certified for Cyber Essentials.
UK GDPR compliant.
We can provide a complete DTAC evidence pack, help you complete DPIA templates, and supply data processing agreements. View full compliance documentation โ
Clinically validated in published, peer-reviewed research with Karolinska Institutet
Roughly twice the effect of traditional treatment when using Evira.
Treatment effects maintained at three-year follow-up. KI 2025.
Compared with 11% in traditional care โ particularly strong in adolescents.
By shifting care from clinic-based to digital-first delivery, Evira reduces environmental impact across the pathway.
Home-based monitoring and digital follow-up replace many in-person visits โ fewer journeys for patients and staff.
The numberless scale is durable, reusable, and refurbishable when returned. Several household members share one device.
Less reliance on printed materials. Digital communication replaces letters and paper forms.
Clinicians can review dashboards and reply to messages remotely, reducing staff travel where appropriate.
A scalable solution for long-term weight management โ built to support ICB and Trust priorities in prevention, inequalities, sustainability and cost efficiency.
Book a demonstration